Many studies have attempted to clarify whether drugs that increase the activity and expression of ACE2 in animals and humans [64, 65] may adversely affect the prognosis of COVID-19 by facilitating the entry of the virus into host cells [56, 64, 66]. Here, ACE2 is linked to COVID-19.